Arcinova
Abstract: Arcinova is a CRDO which operates from a 15,000m2 facility which has benefited from more than 36 years of investment as a key research and development centre for Sanofi and Covance. Arcinova serve the global pharmaceutical and biotechnology communities offering a range of services including drug product manufacture, formulation, bioanalytical and metabolism services, radiolabelling synthesis and synthesis of toxic/highly potent APIs, and can provide both integrated and standalone services.
Description:
Category: Drug Substance
Type: Small Molecules
Contact: Nathalie Huther ([email protected])